Sherise D. Ferguson, M.D.
Department of Neurosurgery, Division of Surgery
In the News
Present Title & Affiliation
Primary Appointment
Professor, Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Vice President, Ambulatory Operations, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Center Medical Director (CMD), Department of Houston Area Location - West Houston, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2006 | University of Chicago, Pritzker School of Medicine, Chicago, Illinois, US, MD |
| 2002 | University of Pennsylvania, Philadelphia, Pennsylvania, US, Master of Liberal Arts, MLA |
| 2000 | University of Virginia, Charlottesville, Virginia, US, Biology, BA |
Postgraduate Training
| 2011-2012 | Enfolded Clinical Fellowship, Neurosurgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2009-2010 | Research Fellowship (NIH R25), University of Chicago, Chicago, Illinois |
| 2006-2013 | Residency, Neurosurgery, University of Chicago, Chicago, Illinois |
Licenses & Certifications
| 2018 | The American Board of Neurological Surgery |
| 2013 | Texas Medical Board |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020
Administrative Appointments/Responsibilities
Associate Vice Present- Ambulatory Operations, MD Anderson Cancer Center, 2026 - Present
Co-Chair, Department of Ambulatory QAPI Council, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Co-Chair, Department of HAL Procedures Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - 2025
Center Medical Director (CMD), Department of Houston Area Location - West Houston, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2025
Departmental EHR Officer, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2018
Other Professional Positions
Awards Committee, Women in Neurosurgery (WINS), 2020 - Present
Fundraising Committee, Women in Neurosurgery (WINS), 2019 - Present
CNS Education Division, SANS Committee, 2019 - Present
Institutional Committee Activities
Member, Institutional Patient Safety Committee (IPSC), 2025 - Present
Member, Reach Executive Committee, 2025 - Present
Member, Clinical Space Committee (Ambulatory Capacity Management Clinic Space Project), 2023 - Present
Member, Ambulatory Core Clinical Leadership Team (CCLT), 2023 - Present
Member, One MD Anderson Facilities Task Force, 2022 - 2025
Member, Procedural Area QAPI Committee, 2022 - 2025
Member, West Houston Quality and Safety Committee, 2020 - 2025
Member, Houston Area Locations (HAL) Quality and Safety Committee, 2020 - Present
Member, Ambulatory QAPI Council, 2020 - 2023
Member, Houston Area Locations (HAL) Procedural Steering Committee, 2020 - Present
Member, Faculty Academic Review Committee (Faculty ARC), 2019 - Present
Member, Communications Committee - WINS, 2019 - 2020
Member - Neurosurgery Representative, Acute and Critical Care Subcommittee, 2018 - Present
Neurosurgery Representative, Focus on Junior Faculty Committee, 2018 - 2020
Member, Medical Records Committee, 2018 - 2022
Member, Council on Gender Inclusiveness, 2015 - 2018
Honors & Awards
| 2025 - Present | Dr. Eugene Newry Memorial Award, Medical Association of the Bahamas |
| 2020 | 2020 Texas Rising Star, Texas Monthly |
| 2020 | Top Neurological Surgeon, Texas Monthly |
| 2019 | Commencement Speaker, University of the Bahamas |
| 2016 | Honor Roll for Excellence in Teaching, Baylor of College of Medicine |
| 2013 | Alpha Omega Alpha |
| 2008 - 2009 | Outstanding Consultant to the Emergency Department, University Chicago Hospitals |
| 2003 - 2004 | American Medical Student Association-Chapter President, University of Chicago, Pritzker School of Medicine |
| 2003 | Honorary Mention for Excellence, NIH/University of Chicago Summer Research Program Forum |
| 2003 | Summer Research Program, NIH/University of Chicago |
| 2002 | Distinguished Final Project, Master of Liberal Arts Program-University of Pennsylvania |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Evaluating the Therapeutic Efficacy of Dual KO NK cells in Melanoma CNS Metastasis. Invited. Brain Metastases Retreat. Houston, Texas, US.
- 2023. Brain Metastases and LMD: Testing Novel Treatment Paradigms in the Clinic and Lab. Invited. TRANSCEND Cancer Initiative. Houston, US.
- 2022. Panel: GME Competency Series. Invited, US.
- 2022. MD Anderson BEST: Expert Panel- Brain Tumors. Invited, US.
- 2022. Surgical Management of Brain Metastasis. Invited. Clinical Neuroscience Conference. Houston, Texas, US.
- 2022. Interrogating the Microbial Landscape of CNS Malignancies. Invited. Moon Shots Scientific Seminar, US.
- 2022. Eloquent Cortex Glioma: Intraoperative Mapping Considerations and Techniques. Invited. Neuro-oncology Fellow Lecture Series. Houston, Texas, US.
- 2021. Surgical Management of Glioblastoma. Invited. Clinical Neuroscience Conference. Houston, Texas, US.
- 2021. Surgical Management of Brain Metastasis. Invited. Clinical Neuroscience Conference. Houston, Texas, US.
- 2021. Practical Intraoperative Mapping Techniques. Invited. Department of Neurosurgery Grand Rounds, US.
- 2021. Phase III randomized controlled trial of pre-operative versus post-operative stereotactic surgery (SRS) for brain metastases. Invited. Division of Surgery Grand Rounds, US.
- 2021. Surgical Management of Brain Metastasis. Invited. General Medical Oncology Grand Rounds. Houston, Texas, US.
- 2021. CNS Lymphoma. Invited. Clinical Neuroscience Conference. Houston, Texas, US.
- 2020. Surgical Management of Brain Metastasis. Invited. Clinical Neuroscience Conference. Houston, Texas, US.
- 2017. Surgical Management of Gliomas. Invited. Department of Radiation Oncology Educational Conference, US.
- 2014. CSF and Hydrocephalus. Invited. The 8th Annual Kempfer Functional Neuroanatomy Seminar. Houston, Texas, US.
- Wading in the Dorsal Stream - A Practical Overview of Language and Intraoperative Mapping. Invited. Baylor Neurosurgery- Grand Rounds. Houston, Texas, US.
National Presentations
- 2025. Low Grade Gliomas Tumor Board. Panelist. SBMT 22nd Annual NeuroTech Convention. Los Angeles, CA, US.
- 2024. The Role of Surgery in Melanoma Brain Metastases. Invited, US.
- 2023. Butterfly Glioma, When to Operate. Invited. Congress of Neurological Surgeons (CNS) Annual Meeting. Washington, DC, US.
- 2023. Brain Metastases and LMD: Testing Novel Treatment Paradigms in the Clinic and Lab. Visiting. Seidman Cancer Center Grand Rounds. Cleveland, OH, US.
- 2023. Pre-operative Stereotactic Radiosurgery. Invited. 2023 Radiosurgery Society Scientific Meeting. Orlando, FL, US.
- 2022. Practical Intraoperative Mapping Techniques. Invited. Congress of Neurological Surgeons (CNS) Annual Meeting 2022. San Francisco, CA, US.
- 2022. A Practical Overview of Intraoperative Mapping. Invited. Advocate Health Chicago Neurosurgery Academic Day. Chicago, Illinois, US.
- 2022. The Role of Surgery in Brain Metastases. Invited. AIM at Melanoma Foundation Survivorship Symposium, US.
- 2022. Preclinical Modeling of LMD and Intrathecal Immunotherapy. Invited. Emerson Cancer Research Symposium. Sonoma, CA, US.
- 2021. Preclinical Modeling of Melanoma Leptomeningeal Disease (LMD) and Intrathecal Immunotherapy. Poster. Melanoma Research Foundation Summit, US.
- 2019. Comprehensive spatial characterization of immune cells in the CNS brain tumor microenvironment. Poster. Society for Neuro-Oncology (SNO). Phoenix, AZ, US.
- 2018. Impact of Surgical Resection in Patients with Multiple Brain Metastases. Conference. Tumor Section Satellite Symposium. Houston, TX, US.
- 2017. Pan-cancer profiles of brain metastases: prioritization of therapeutic targets. Conference. 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. San Francisco, CA, US.
- 2008. Prospective Self-Reported Outcomes Analysis of 108 patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion (Oral Presentation). Conference. AANS/CNS Section on Disorders of the Spine and Peripheral Nerves Annual Meeting. Orlando, FL, US.
International Presentations
- 2025. Evolution of the Surgical Management of Metastatic Brain Cancer. Invited. The Medical Association of the Bahamas 53rd Annual Scientific Conference. Nassau, BS.
- 2022. Evolution of Surgical Clinical Trials for Brain Metastasis. Invited. British Neuro-Oncology Society Conference 2022. Liverpool, GB.
- 2022. Keynote Speech. Invited. Alpha Kappa Alpha 44th Honours Day and Scholarship Ceremony, US.
- 2021. Surgical Management of Brain Metastasis. Invited. Neuro-Oncology Course, CL.
- 2019. Commencement Speech - Class of 2019. Invited. University of the Bahamas, BS.
Formal Peers
- 2022. A Practical Overview of Intraoperative Mapping. Visiting. Chicago, US.
- 2022. The Role of Surgery in Brain Metastases. Visiting, US.
Grant & Contract Support
| Date: | 2025 - 2026 |
| Title: | Evaluating the therapeutic efficacy of NK cell immunotherapy for CNS metastasis |
| Funding Source: | American Brain Tumor Association |
| Role: | PI |
| ID: | MBTC250001 |
| Date: | 2023 - 2024 |
| Title: | McDougal Brain Metastasis Research Award |
| Funding Source: | McDougal Brain Metastasis |
| Role: | Co-PI |
| ID: | Brain Mets RFA 2023-005 |
| Date: | 2022 - 2025 |
| Title: | Elucidating the Role of the Gut and Tumor Microbiome in Malignant Glioma |
| Funding Source: | NIH/NINDS-R21 |
| Role: | Co-PI |
| ID: | 1R21NS130323-01 |
| Date: | 2022 - 2024 |
| Title: | Combined intrathecal immunotherapeutic strategies for melanoma LMD |
| Funding Source: | Melanoma Research Alliance |
| Role: | PI |
| Date: | 2020 - 2022 |
| Title: | Safety and Efficacy of Therapeutic Exosomes in Models of Glioblastoma Multiforme and Leptomeningeal Disease |
| Funding Source: | Codiak BioSciences, Inc |
| Role: | Co-PI |
| ID: | LS2021-00058585 |
| Date: | 2020 - 2022 |
| Title: | GBM Moon Shot at MD Anderson Cancer Center - Priority Project 1: CATALYST |
| Funding Source: | UT MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2020 - 2022 |
| Title: | Preclinical modeling of melanoma leptomeningeal disease (LMD) and intrathecal checkpoint blockade immunotherapy |
| Funding Source: | Emerson Collective |
| Role: | PI |
| ID: | 691390 |
| Date: | 2020 - 2028 |
| Title: | Transforming the Standard of Care: A Personalized Approach for Patients with Cancer Metastatic to the Brain |
| Funding Source: | Brockman Foundation |
| Role: | Co-PI |
| ID: | FP00007917 |
| Date: | 2019 - 2022 |
| Title: | SPORE in Brain Cancer - Animal Core |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 2 P50 CA127001-11A1 |
| Date: | 2019 - 2021 |
| Title: | Preclinical Modeling of Melanoma Leptomeningeal Disease (LMD) and Intrathecal Checkpoint Inhibitor Immunotherapy |
| Funding Source: | Melanoma SPORE, Career Enhancement Program (CEP) |
| Role: | PI |
| ID: | FP0004039 |
| Date: | 2017 - 2020 |
| Title: | Targeting the Wnt signaling pathway for the treatment of malignant glioma |
| Funding Source: | Institutional Research Grant (IRG) from MD Anderson |
| Role: | PI |
| Date: | 2011 - 2012 |
| Title: | Preparing Trainees in Neurology and Neurosurgery for Academic Research careers |
| Funding Source: | NIH/NIDDS |
| Role: | Co-I |
| ID: | R25 NS065744-01 |
| Title: | Evaluating the therapeutic efficacy of NK cell immunotherapy for melanoma CNS metastatic disease |
| Funding Source: | Institute of Cellular Therapy- MD Anderson Cancer Center |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Goethe, E, Srinivasan, S, Kumar, S, Prabhu, SS, Gubbiotti, M, Ferguson, SD. High-Grade Astrocytoma with Piloid Features. Acta Neuropathologica Communications 13(1), 2025. e-Pub 2025. PMID: 40270074.
- Kumar, S, Pelster, MS, Hasanov, M, Guerrieri, R, Hudgens, CW, Ledesma, D, Wang, F, Fischer, G, Simon, JM, Haydu, LE, Katlowitz, KV, Yennu Nanda, VG, McQuade, JL, Kwong, L, Huse, J, Lazar, A, Tetzlaff, M, Gershenwald, JE, Joon, A, Chen, K, Li, Z, Ram, P, Ferguson, SD, Davies, MA. Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis. Acta Neuropathologica Communications 13(1), 2025. e-Pub 2025. PMID: 40229864.
- Goethe EA, Alfattal R, Srinivasan S, Dasgupta P, Puduvalli V, Weathers SP, Ballester LY, Weinberg JS, Prabhu S, Ferguson SD, Gubbiotti MA. High-grade glioma with pleomorphic and pseudopapillary features: a single-institution series of three cases. Acta Neuropathol Commun 13(1):176, 2025. e-Pub 2025. PMID: 40826136.
- Dagher SA, Johnson JM, Mohamed RMM, Ansari S, Mawlawi O, Liu HL, Wintermark M, Schellingerhout D, Flynt L, Yeboa DN, Weinberg JS, Ferguson SD, Gule-Monroe MK. Study of 18 F-fluciclovine PET for serial assessment of glioblastoma tumor volumes during surgery and radiotherapy. J Neurooncol, 2025. e-Pub 2025. PMID: 40591209.
- Beckham TH, Cha EE, Rooney MK, Tom MC, Perni S, McAleer MF, Li J, Kudchadker RJ, Prajapati S, Zlateva Y, Kaya D, Ene CI, Ferguson SD, Huse JT, Prabhu SS, Weinberg JS. Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases. J Neurooncol, 2025. e-Pub 2025. PMID: 40549120.
- Yeboa DN, Li J, Lin R, Prabhu SS, Beckham TH, Woodhouse K, Swanson TA, Weinberg JS, Wang X, Chi X, Ejezie CL, Suki D, Wang C, Ene C, McCutcheon IE, McGovern S, McAleer MF, Tom M, Ghia A, Perni S, Jiang W, De B, Chung C, Kim BYS, O'Brien BJ, Huse JT, Wefel JS, Court L, Tawbi H, Janku F, Guha-Thakurta N, Debnam JM, Johnson J, Taslicay CA, Alvarez-Breckenridge C, Raza SM, Heimberger AB, DeMonte F, North R, Briere TM, de Groot JF, Sawaya R, Grosshans D, Lang FF, Rao G, Ferguson SD. Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial. JAMA Oncol, 2025. e-Pub 2025. PMID: 40531511.
- Bollo RJ, Ho WS, Strauss I, Ferguson SD, Menacho ST. Introduction. Calibrating the utility of laser interstitial thermal therapy in neurosurgery: a once-novel surgical treatment finds it place in the armamentarium. Neurosurg Focus 57(5):E1, 2024. e-Pub 2024. PMID: 39486074.
- Saberian, C, Milton, D, Simon, JM, Amaria, RN, Diab, A, McQuade, JL, Patel, SP, Tawbi, H, Yee, C, Wong, MK, McCutcheon, IE, Davies, MA, Ferguson, SD, Glitza, IC. Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neuro-Oncology Practice 11(4):452-463, 2024. e-Pub 2024. PMID: 39006528.
- Teo JM, Kumar VA, Lee J, Eldaya RW, Hou P, Jen ML, Noll KR, Wei P, Ferguson SD, Prabhu SS, Wintermark M, Liu HL. Probabilistic Presurgical Language Functional MRI Atlas of Brain Tumor Patients. AJNR Am J Neuroradiol, 2024. e-Pub 2024. PMID: 38889968.
- Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract 11(3):266-274, 2024. e-Pub 2024. PMID: 38737610.
- Lee, J, Kumar, VA, Teo, JM, Eldaya, R, Hou, P, Noll, KR, Ferguson, SD, Prabhu, SS, Liu, HL. Comparative analysis of brain language templates with primary language areas detected from presurgical fMRI of brain tumor patients. Brain and Behavior 14(6), 2024. e-Pub 2024. PMID: 38898620.
- Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE. Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15(1):3728, 2024. e-Pub 2024. PMID: 38697991.
- Huntoon KM, Gasco J, Glitza Oliva IC, Ferguson SD, Majd NK, McCutcheon IE. Ventriculoperitoneal shunting with an on-off valve for patients with leptomeningeal metastases and intracranial hypertension. Neurooncol Pract 11(1):56-63, 2024. e-Pub 2024. PMID: 38222058.
- Buszek SM, Tran B, Long JP, Luo D, Suki D, Li J, Ferguson S, Chung C. Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation. Pract Radiat Oncol, 2023. e-Pub 2023. PMID: 37295724.
- Haider AS, McCutcheon IE, Ene CI, Fuller GN, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya R. Subependymomas of the fourth ventricle: To operate or not to operate?. J Clin Neurosci 118:147-152, 2023. e-Pub 2023. PMID: 37944358.
- Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, Gopal R, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L, Bloom ES, Chun SG. A phase II clinical trial of frameless fractionated stereotactic radiotherapy for brain metastases. JNCI Cancer Spectr 7(6):pkad093, 2023. e-Pub 2023. PMID: 37944053.
- Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2023. PMID: 36510640.
- Glitza Oliva IC, Ferguson SD, Bassett R, Foster AP, John I, Hennegan TD, Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S, Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuade JL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N, Wargo JA, Burton EM, Tawbi HA, Davies MA. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med 29(4):898-905, 2023. e-Pub 2023. PMID: 36997799.
- Ziyaee H, Cardenas CE, Yeboa DN, Li J, Ferguson SD, Johnson J, Zhou Z, Sanders J, Mumme R, Court L, Briere T, Yang J. Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection. Adv Radiat Oncol 8(1):101085, 2023. e-Pub 2023. PMID: 36299565.
- Yeh MY, Chen HS, Hou P, Kumar VA, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Schomer DF, Peng HH, Liu HL. Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas. J Magn Reson Imaging 56(6):1863-1871, 2022. e-Pub 2022. PMID: 35396789.
- Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB. Central nervous system immune interactome is function of cancer lineage, tumor microenvironment and STAT3 expression. JCI Insight 7(9):e157612, 2022. e-Pub 2022. PMID: 35316217.
- Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol 38(13):1429-1441, 2022. e-Pub 2022. PMID: 31990608.
- Shepard MJ, Haider AS, Prabhu SS, Sawaya R, DeMonte F, McCutcheon IE, Weinberg JS, Ferguson SD, Suki D, Fuller GN, Lang FF. Long term outcomes following surgery for pineal region tumors. J Neurooncol 156(3):491-498, 2022. e-Pub 2022. PMID: 35083579.
- Al-Holou WN, Suki D, Hodges TR, Everson RG, Freeman J, Ferguson SD, McCutcheon IE, Prabhu SS, Weinberg JS, Sawaya R, Lang FF. Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas. J Neurosurg 137(4):1015-1025, 2022. e-Pub 2022. PMID: 34996044.
- Muir M, Prinsloo S, Michener H, Traylor JI, Patel R, Gadot R, de Almeida Bastos DC, Kumar VA, Ferguson S, Prabhu SS. TMS Seeded Diffusion Tensor Imaging Tractography Predicts Permanent Neurological Deficits. Cancers (Basel) 14(2):340, 2022. e-Pub 2022. PMID: 35053503.
- Najem, H, Marisetty, AL, Horbinski, C, Long, JP, Huse, J, Glitza, IC, Ferguson, SD, Kumthekar, P, Wainwright, DA, Chen, P, Lesniak, MS, Burks, JK, Heimberger, AB. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Frontiers in immunology 12(745893), 2021. e-Pub 2021. PMID: 34691054.
- Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology 97(5):248-250, 2021. e-Pub 2021. PMID: 33931525.
- Noll KR, Chen HS, Wefel JS, Kumar VA, Hou P, Ferguson SD, Rao G, Johnson JM, Schomer DF, Suki D, Prabhu SS, Liu HL. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection. Neurosurgery 88(3):544-551, 2021. e-Pub 2021. PMID: 33080024.
- Noll K, Mitchell D, Chen H, Wefel J, Kimar V, Hou P, Ferguson S, Rao F, Johnson J, Schomer D, Prabhu S, Liu HL. Alterations in structural connectomic properties associated with neurocognitive changes following glioma resection. Neuro Oncology 23(6):544-551, 2021. e-Pub 2021. PMID: 33080024.
- Ferguson SD, Hodges TR, Majd NK, Alfaro-Munoz K, Al-Holou WN, Suki D, de Groot JF, Fuller GN, Xue L, Li M, Jacobs C, Rao G, Colen RR, Xiu J, Verhaak R, Spetzler D, Khasraw M, Sawaya R, Long JP, Heimberger AB. A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram. Neurooncol Adv 3(1):vdaa146, 2021. e-Pub 2021. PMID: 33426529.
- Anakwenze CP, McGovern S, Taku N, Liao K, Boyce-Fappiano DR, Kamiya-Matsuoka C, Ghia A, Chung C, Trifiletti D, Ferguson SD, Li J, Yeboa DN. Association between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg 141:e133-e144, 2020. e-Pub 2020. PMID: 32407910.
- Ott M, Tomaszowski KH, Marisetty A, Kong LY, Wei J, Duna M, Blumberg K, Ji X, Jacobs C, Fuller GN, Langford LA, Huse JT, Long JP, Hu J, Li S, Weinberg JS, Prabhu SS, Sawaya R, Ferguson S, Rao G, Lang FF, Curran MA, Heimberger AB. Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration. JCI Insight 5(17):e134386, 2020. e-Pub 2020. PMID: 32721947.
- Hsu AL, Chen HS, Hou P, Wu CW, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Chen JH, Liu HL. Presurgical resting-state functional MRI language mapping with seed selection guided by regional homogeneity. Magn Reson Med 84(1):375-383, 2020. e-Pub 2020. PMID: 31793025.
- Kumar VA, Heiba IM, Prabhu SS, Chen MM, Colen RR, Young AL, Johnson JM, Hou P, Noll K, Ferguson SD, Rao G, Lang FF, Schomer DF, Liu HL. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging 20(1):47, 2020. e-Pub 2020. PMID: 32653026.
- de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O'Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA, Mandel J, Wu J, Yuan Y, Zhou S, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, McCutcheon IE, Lang FF, Ferguson SD, Sawaya R, Colen R, Yadav SS, Blando J, Vence L, Allison J, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol 22(4):539-549, 2020. e-Pub 2020. PMID: 31755915.
- Al-Holou WN, Hodges TR, Everson RG, Freeman J, Zhou S, Suki D, Rao G, Ferguson SD, Heimberger AB, McCutcheon IE, Prabhu SS, Lang FF, Weinberg JS, Wildrick DM, Sawaya R. Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes. Neurosurgery 86(1):112-121, 2020. e-Pub 2020. PMID: 30799490.
- Glitza IC, Ferguson SD, Guha-Thakurta N. Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient. J Neurooncol 133(3):663-665, 2019. e-Pub 2019. PMID: 28528423.
- Ferguson SD, Bindal S, Bassett RL, Haydu LE, McCutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta N, Tetzlaff MT, Tawbi H, Davies MA, Glitza IC. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol 142(3):499-509, 2019. e-Pub 2019. PMID: 30847840.
- Fischer GM, Jalali A, Kircher DA, Lee WC, McQuade JL, Haydu LE, Joon AY, Reuben A, de Macedo MP, Carapeto FCL, Yang C, Srivastava A, Ambati CR, Sreekumar A, Hudgens CW, Knighton B, Deng W, Ferguson SD, Tawbi HA, Glitza IC, Gershenwald JE, Vashisht Gopal YN, Hwu P, Huse JT, Wargo JA, Futreal PA, Putluri N, Lazar AJ, DeBerardinis RJ, Marszalek JR, Zhang J, Holmen SL, Tetzlaff MT, Davies MA. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. Cancer Discov 9(5):628-645, 2019. e-Pub 2019. PMID: 30787016.
- Yeboa DN, Liao KP, Guadagnolo BA, Rao G, Bishop A, Chung C, Li J, Tatsui CE, Rhines LD, Ferguson S, Paulino AC, Ghia AJ. National Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas. World Neurosurg 124:e580-e594, 2019. e-Pub 2019. PMID: 30641236.
- Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, O'Brien BJ, Sawaya R, Verhaak RGW, Reddy SK, Priebe W, Gatalica Z, Spetzler D, Heimberger AB. Profiles of Brain Metastases: Prioritization of Therapeutic Targets. Int J Cancer 143(11):3019-3026, 2018. e-Pub 2018. PMID: 29923182.
- Zhang Z, Yang J, Ho A, Jiang W, Logan J, Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Li J. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol 28(8):3570-3571, 2018. e-Pub 2018. PMID: 29541912.
- Ferguson SD, Zhou S, Huse JT, de Groot JF, Xiu J, Subramaniam DS, Mehta S, Gatalica Z, Swensen J, Sanai N, Spetzler D, Heimberger AB. Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas. J Neuropathol Exp Neurol 77(6):437-442, 2018. e-Pub 2018. PMID: 29718398.
- Zhang Z, Yang J, Ho A, Jiang W, Logan J, Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, Fave X, Zhang L, Mackin D, Court LE, Li J. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images. Eur Radiol 28(6):2255-2263, 2018. e-Pub 2018. PMID: 29178031.
- De Groot JF, Penas-Prado M, Mandel JJ, O'Brien BJ, Weathers SPS, Zhou S, Hunter K, Alfaro-Munoz K, Fuller GN, Huse J, Rao G, Weinberg JS, Prabhu SS, Fergusion SD, Yuan Y, Vence LM, Allison JP, Sharma P, Heimberger AB. Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma. Journal of Clinical Oncology 36(15_suppl):2008-2008, 2018. e-Pub 2018. PMID: 31755915.
- Ferguson SD, Levine NB, Suki D, Tsung AJ, Lang FF, Sawaya R, Weinberg JS, McCutcheon IE. The surgical treatment of tumors of the fourth ventricle: a single-institution experience. J Neurosurg 128(2):1-13, 2018. e-Pub 2018. PMID: 28409732.
- Ferguson SD, Zhou S, Xiu J, Hashimoto Y, Sanai N, Kim L, Kesari S, de Groot J, Spetzler D, Heimberger AB. Ependymomas overexpress chemoresistance and DNA repair-related proteins. Oncotarget 9(8):7822-7831, 2018. e-Pub 2018. PMID: 29487694.
- Hsu AL, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen JH, Liu HL. IClinfMRI Software for Integrating Functional MRI Techniques in Presurgical Mapping and Clinical Studies. Front Neuroinform 12:11, 2018. e-Pub 2018. PMID: 29593520.
- Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040-1048, 2017. e-Pub 2017. PMID: 28687375.
- Ferguson SD, Xiu J, Weathers SP, Zhou S, Kesari S, Weiss SE, Verhaak RG, Hohl RJ, Barger GR, Reddy SK, Heimberger AB. GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget 7(43):69466-69478, 2016. e-Pub 2016. PMID: 27579614.
- Hodges TR, Ferguson SD, Caruso HG, Kohanbash G, Zhou S, Cloughesy TF, Berger MS, Poste GH, Khasraw M, Ba S, Jiang T, Mikkelson T, Yung WK, de Groot JF, Fine H, Cantley LC, Mellinghoff IK, Mitchell DA, Okada H, Heimberger AB. Prioritization schema for immunotherapy clinical trials in glioblastoma. Oncoimmunology 5(6):e1145332, 2016. e-Pub 2016. PMID: 27471611.
- Ho JC, Luo D, Guha-Thakurta N, Ferguson SD, Ghia AJ, Yang JN, Brown PD, Voong KR. Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins. Neurosurgery 78(6):877-82, 2016. e-Pub 2016. PMID: 26488329.
- Pan IW, Ferguson SD, Lam S. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010. J Clin Neurosci 22(10):1575-81, 2015. e-Pub 2015. PMID: 26122381.
- Ferguson SD, Waguespack SG, Langford LA, Ater JL, McCutcheon IE. Fatal Juvenile Xanthogranuloma presenting as a sellar lesion. Case report and literature review. Childs Nerv Syst 31(5):777-84, 2015. e-Pub 2015. PMID: 25503249.
- Balyasnikova IV, Prasol MS, Ferguson SD, Han Y, Ahmed AU, Gutova M, Tobias AL, Mustafi D, Rincón E, Zhang L, Aboody KS, Lesniak MS. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther 22(1):140-8, 2014. e-Pub 2014. PMID: 24002694.
- Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 73(13):3913-26, 2013. e-Pub 2013. PMID: 23636127.
- Thaci B, Ulasov IV, Ahmed AU, Ferguson SD, Han Y, Lesniak MS. Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Ther 20(3):318-27, 2013. e-Pub 2013. PMID: 22673390.
- Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, Bögler O, Heimberger AB, Rao G. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol 14(9):1136-45, 2012. e-Pub 2012. PMID: 22753228.
- Lee I, Fox PS, Ferguson SD, Bassett R, Kong LY, Schacherer CW, Gershenwald JE, Grimm EA, Fuller GN, Heimberger AB. The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival. Oncotarget 3(3):336-44, 2012. e-Pub 2012. PMID: 22488042.
- Balyasnikova IV, Ferguson SD, Han Y, Liu F, Lesniak MS. Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett 310(2):148-59, 2011. e-Pub 2011. PMID: 21802840.
- Ferguson SD, Musleh W, Gurbuxani S, Shafizadeh SF, Lesniak MS. Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma. J Clin Neurosci 17(5):666-9, 2010. e-Pub 2010. PMID: 20202849.
- Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One 5(3):e9750, 2010. e-Pub 2010. PMID: 20305783.
- Ferguson SD, Rosen DS, Bardo D, MacDonald RL. Arterial Diameters on Catheter and Computed Tomographic Angiography. World Neurosurg 73(3):165-73, 2010. e-Pub 2010.
- Ferguson SD, Coccaro EF. History of mild to moderate traumatic brain injury and aggression in physically healthy participants with and without personality disorder. J Pers Disord 23(3):230-9, 2009. e-Pub 2009. PMID: 19538079.
- Rosen DS, Ferguson SD, Ogden AT, Huo D, Fessler RG. Obesity and self-reported outcome after minimally invasive lumbar spinal fusion surgery. Neurosurgery 63(5):956-60; discussion 960, 2008. e-Pub 2008. PMID: 19005386.
- Ferguson SD, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60(4):658-67; discussion 667, 2007. e-Pub 2007. PMID: 17415202.
- Ferguson SD, Michael N, Frim DM. Observations regarding failure of cerebrospinal fluid shunts early after implantation. Neurosurg Focus 22(4):E7, 2007. e-Pub 2007. PMID: 17613196.
- Fagan LH, Ferguson S, Yassari R, Frim DM. The Chiari pseudotumor cerebri syndrome: symptom recurrence after decompressive surgery for Chiari malformation type I. Pediatr Neurosurg 42(1):14-9, 2006. e-Pub 2006. PMID: 16357496.
- Palmer SC, Coyne JC, Ferguson S. Validity of Horowitz's Impact of Events Scale as a Screen for PTSD in a Sample of Breast Cancer Patients. Annals of Behavioral Medicine 24, 2002. e-Pub 2002.
- Mahajan A, Ahmed S, Li J, McAleer MF, Weinberg J, Brown PD, Prabhu S, Lang FF, McGovern SL, McCutcheon IE, Heimberger A, Sulman EP, Ghia AJ, Ferguson S, Hess K, Rao G. Postoperative Stereotactic Radiosurgery Versus Observation for Completely Resected Brain Metastases: Results of a Prospective Randomized Study. American Society of Therapeutic Radiation Oncology (ASTRO) Annual Meeting.
Invited Articles
- Smalley I, Boire A, Brastianos P, Kluger HM, Hernando-Monge E, Forsyth PA, Ahmed KA, Smalley KSM, Ferguson S, Davies MA, Glitza Oliva IC. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment Cell Melanoma Res 37(1):51-67, 2024. e-Pub 2024. PMID: 37622466.
- Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, Knisely JPS, Merlino G, Nguyen DX, Pacold ME, Perez-Guijarro E, Smalley KSM, Tawbi HA, Wen PY, Davies MA, Kluger HM, Mehnert JM, Hernando E. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res 35(6):554-572, 2022. e-Pub 2022. PMID: 35912544.
- Giridharan N, Glitza Oliva IC, O'Brien BJ, Parker Kerrigan BC, Heimberger AB, Ferguson SD. Targeting the Tumor Microenvironment in Brain Metastasis. Neurosurg Clin N Am 31(4):641-649, 2020. e-Pub 2020. PMID: 32921358.
- Ferguson SD, Wagner KM, Prabhu SS, McAleer MF, McCutcheon IE, Sawaya R. Neurosurgical management of brain metastases. Clin Exp Metastasis 34(6-7):377-389, 2017. e-Pub 2017. PMID: 28965270.
- Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB. Tumor Vaccines for Malignant Gliomas. Neurotherapeutics 14(2):345-357, 2017. e-Pub 2017. PMID: 28389997.
- Hodges TR, Ferguson SD, Heimberger AB. Immunotherapy in glioblastoma: emerging options in precision medicine. CNS Oncol 5(3):175-86, 2016. e-Pub 2016. PMID: 27225028.
- Ferguson SD, Srinivasan VM, Heimberger AB. The role of STAT3 in tumor-mediated immune suppression. J Neurooncol 123(3):385-94, 2015. e-Pub 2015. PMID: 25700834.
Review Articles
- Piña Y, Yadugiri S, Yeboa DN, Ferguson SD, Forsyth PA, Oliva ICG. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma. Curr Oncol Rep 24(1):43-54, 2022. e-Pub 2022. PMID: 35059999.
- Ene CI, Ferguson SD. Surgical Management of Brain Metastasis: Challenges and Nuances. Front Oncol 12:847110, 2022. e-Pub 2022. PMID: 35359380.
- Ferguson SD, Fomchenko EI, Guerrieri RA, Glitza Oliva IC. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD). Front Oncol 11:800053, 2021. e-Pub 2021. PMID: 35096602.
- Ferguson SD, McCutcheon IE. Surgical Management of Gliomas in Eloquent Cortex. Prog Neurol Surg 30:159-172, 2018. e-Pub 2018. PMID: 29241173.
- Ferguson SD, Momin EN, Weinberg JS. Surgical Management of Recurrent Intracranial Gliomas. Prog Neurol Surg 30:218-231, 2018. e-Pub 2018. PMID: 29241177.
- Ferguson SD, Srinivasan VM, Ghali MG, Heimberger AB. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?. Immunotherapy 8(4):413-23, 2016. e-Pub 2016. PMID: 26973123.
- Ferguson SD, Ahmed AU, Thaci B, Mercer RW, Lesniak MS. Crossing the Boundaries: Stem Cells and Gene Therapy. Discov Medicine 9(46):192-6, 2011. e-Pub 2011. PMID: 20350484.
- Ferguson SD. Malignant Gliomas: Diagnosis and Treatment. Dis Mon 57(10):558-69, 2011. e-Pub 2011.
- Ferguson SD, Foster K, Yamini B. Convection-Enhanced Delivery for Treatment of Brain Tumors. Expert Review Anticancer Therapy 7:79-85, 2007. e-Pub 2007.
- Ferguson S, Lesniak MS. Convection enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors. Current Drug Delivery 4(2):169-80, 2007. e-Pub 2007.
- Ferguson S, Lesniak MS. Percival Bailey and the classification of brain tumors. Neurosurg Focus 18(4):e7, 2005. e-Pub 2005. PMID: 15844870.
Abstracts
- Ferguson SD, Faraj CA. Factors Associated with Overall Survival and 90-day Mortality Following Resection of Melanoma Brain Metastases. Brain Metastasis Clinic and Research Program 2025 Brain Metastasis Research Retreat.
- Ferguson S, Frim DM. Observations regarding CSF shunt complications in a large single-institution review. Annual Conference of International Pediatric Neurosurgery.
- Rosen DS, Ogden AT, Ferguson SD, Burks A, Johns L, Fessler RG. Single vs. Multilevel Lumbar Fusion Surgery: Comparison of Self-Reported Outcomes, Operative Time, Estimated Blood Loss, and Length of Hospital Stay in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion. AANS/CNS Section on Disorders of the Spine and Peripheral Nerves.
- Ferguson S, Rosen DS, Bardo D, Macdonald RL. Can CT Angiogram Diagnose Cerebral Vasospasm?. AANS/CNS Cerebrovascular Section, American Society of Interventional & Therapeutic Neuroradiology.
- Ferguson S, Rosen DS, Bardo D, Macdonald RL. Can CT Angiogram Diagnose Cerebral Vasospasm?. American Association of Neurological Surgeons (AANS) Annual Meeting.
- Ferguson S, Myers GR, Rosen DS, Frim DM. Why Do Some Patients Need So Many Shunt Revisions? Predictors of Shunt Survival in a Large Population of Patients Undergoing Multiple Shunt Revisions. Congress of Neurological Surgeons (CNS) Annual Meeting.
- Ferguson S, Myers GR, Rosen DS, Frim DM. Predictors of Shunt Survival After Revision. AANS/CNS Section on Pediatric Neurological Surgery.
- Ferguson SD, MacDonald RL. Predictors of Cerebral Infraction. International Stroke Conference: AANS/CNS Cerebrovascular Section and The American Society of Interventional & Therapeutic Neuroradiology.
- Ferguson SD, Lesniak M. Bone-flap sparing surgical debridement of post-craniotomy infections. Congress of Neurological Surgeons (CNS) Annual Meeting.
- Rosen DS, Ogden AT, Ferguson SD, Burks A, Johns L, Fessler RG. Prospective Self-Reported Outcomes Analysis of 108 Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion. AANS/CNS Section on Disorders of the Spine and Peripheral Nerves.
- Rosen DS, Ogden A, Ferguson SD, Johns L, Burks A, Fessler RG. Body Mass Index does not correlate with self-reported outcome after minimally invasive lumbar fusion surgery. American Association of Neurological Surgeons (AANS) Annual Meeting.
- Rosen DS, Ferguson SD, Ogden AT, Burks A, Johns L, Fessler RG. Body Mass Index does not correlate with self-reported outcome after minimally invasive lumbar fusion surgery. Lumbar Spine Research Society.
- Rosen DS, Ferguson SD, Ogden A, Burks A, Johns L, Fessler RG. Predictors of Length of Hospital Stay in Patients Undergoing Minimally Invasive Lumbar Fusion Surgery. American Association of Neurological Surgeons (AANS) Annual Meeting.
- LaRiviere MJ, Mansour N, Galanopoulos N, Rawlani V, Prem K, Ferguson SD, Arsoniadis E, Spretz R, Larsen G, Nunez L, Kang S, Weichselbaum RR, Yamini B. Convection Enhanced Delivery of Biodegradable Nanoparticles for the Treatment of Malignant Glioma. Congress of Neurological Surgeons (CNS) Annual Meeting.
- Balyasnikova IV, Ferguson SD, Han Y, Lesniak MS. Dual Effect of Mesenchymal Stem Cells Genetically Modified with a Single-Chain Antibody Against EGFRvIII on the Targeting and Growth of EGFRvIII Expressing Experimental Glial Tumors. ASGCT Clinical Trials Training Course and 13th Annual Meeting.
- Balyasnikova IV, Ferguson SD, Prasol MS, Ahmed, AU, Han Y, Lesniak MS. The therapeutic basis of intranasal stem cell delivery for the treatment of glioblastoma. Society of Neuro-Oncology (SNO) Annual Meeting.
- Kong LY, Doucette T, Ferguson SD, Hachem J, Yang Y, Wei J, Priebe W, Fuller GN, Qiao W, Rao G, Heimberger AB. Chemotherapeutic modulation of the glioma development and invasion in vivo. Society of Neuro-Oncology (SNO) Annual Meeting.
- Ho JC, Luo D, Guha-Thakurta N, Ferguson SD, Ghia AJ, Yang JN, Brown PD, Voong KR. Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins. Society of Neuro-Oncology (SNO) Annual Meeting.
- Lin J, Fuentes D, Weinberg J, Prabhu S, Ferguson S, McCutcheon IE, Fuller GN, Hazle JD, Schellingerhout D. Development of a prediction technique for tissue features in brain tumors based on radiologic-pathologic correlations. Division of Diagnostic Imaging Trainee Research Symposium.
- Osborne E, Ferguson S, Guha-Thakutra N, Brown P, McAleer MF. Gamma Knife stereotactic radiosurgery for solitary brain metastses with baseline edema: feasibility and outcomes. 18th Leksell Gamma Knife Society.
- Xiu J, Ferguson SD, Reddy SK, Kesari S, Weiss SE, Hohl RJ, Barger G, Heimberger AB. Comparison of molecular alteration in glioblastoma tumors from old and young patients. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Mahajan A, Ahmed S, Li J, McAleer MF, Weinberg J, Brown PD, Lang FF, McGovern SL, McCutcheon IE, Heimberger A, Sulman EP, Ghia AJ, Ferguson S, Hess K, Rao G. Post-operative stereotactic radiosurgery vs. observation for completely resected brain metastases: results of a prospective randomized trial. American Society of Therapeutic Radiation Oncology (ASTRO) Annual Meeting.
- Bindal S, Ferguson SD, Davies MA, Haydu L, Jr BR, McCutcheon IE, Glitza IC. Leptomeningeal disease (LMD) from metastatic melanoma: a single institution experience and predictors of survival. Society for Melanoma Research.
- Nam J, Harrision RA, Weather SP, Pillainayagam C, DeGroot JF, Kamiya-Matsuoka C, Loghin ME, Penas-Prado M, Yung WK, Li J, Ferguson SD, O’Brien BJ. Association of clinical phenotype and treatment history with survival in adult brainstem glioblastoma. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Wang X, Jing L, McAleer MF, McGovern SL, Ghia AJ, Sulman EP, Brown PD, Jr LF, Ferguson SD, McCutcheon IE, Prabhu SS, Heimberger AB, Weinberg J, Sawaya R, Ahmed S, Luo D, Rao G, Mahajan A. Patterns of Failure after Resection Followed by Gamma Knife Radiosurgery to the Surgical Cavity. 13th Congress of the International Stereotactic Radiosurgery Society (ISRS).
- De Groot J, Penas-Prado M, Mandel JJ, O'Brien BJ, Weathers SP, Zhou S, Hunter K, Alfaro K, Fuller GN, Huse J, Rao G, Weinberg S, Prabhu S, Ferguson SD, Ying Y, Vence, LM, Allison JP, Sharma P, Heimberger A. Window-of-opportunity clinical trial of a PD-1 inhibitor in patients with recurrent glioblastoma. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Glitza IC, Ma J, Ferguson SD, Bassett Jr RL, Haydu L, Davies MA. Characteristics of metastatic melanoma (MM) patients with leptomeningeal disease (LMD) and survival of > 1 year. European Society for Medical Oncology (ESMO).
- Ferguson S, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz M, Piccioni D, Suyun H, Davies M, Glitza I, Heymach J, Zhang J, Ibrahim N, de Groot J, McCarty J, O'Brien BJ, Sawaya R, Verhaak R, Reddy S, Priebe W, Spetzler D, Heimberger A. Pan-Cancer Profiles of Brain Metastases: Prioritization of Therapeutic Targets. Society for Neuro-Oncology (SNO) Annual Meeting.
- Bastos DC, Gogia B, Tummala S, Ferguson S, Lang FF, McCutcheon I, Weinberg JS, Payne J, Connelly K, Prabhu SS. MDA Experience of Language Mapping Using TMS in Brain Tumor Patients. Society of Neuro-Oncology (SNO) Annual Meeting.
- Zinn PO, Abrol S, Kotrotsou A, Hassan A, Elshafeey, Idris T, Manohar N, Hassan I, Salek K, Farid N, McDonald C, Weathers SP, Bahrami N, Bergamschi S, Elakkad A, Alfora-Munoz K, Moron F, Huse J, Weinberg JS, Ferguson SD, Kogias E, Heimberger AB, Sawaya R, Kumar AM, DeGroot J, Law M, Colen RR. Radiomic machine learning algorithms discriminate pseudo-progression from true progression in glioblastoma patients: A Multi-Institutional Study. Congress of Neurological Surgeons (CNS) Annual Meeting.
- Abrol S, Kotrotsou A, Hassan A, Elfshafeey N, Idris T, Manohar N, Agarwal A, Hassan I, Salek K, Farid N, McDonald C, Weathers SP, Bahrami N, Bergamaschi S, Elakkad A, Alfaro-Munoz K, Moron F, Huse J, Weinberg J, Ferguson S, Kogias E, Heimberger A, Sawaya R, Kumar A, deGroot J, Law M, Zinn P, Colen R. Radiomics discriminates pseudo-progression from true progression in glioblastoma patients: A large-scale multi-institutional study. Cancer Imaging and Intervention Conference.
- Hsu AL, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen JH, Liu HL. A software package designed to integrate advanced fMRI methods for presurgical mapping and clinical studies (IClinfMRI). Joint Annual Meeting ISMRM-ESMRMB.
- Chen H, Noll K, Prabhu S, Kuma V, Hou P, Ferguson S, Rao G, Bradshaw M, Johnson J, Schomer D, Lu H. Functional Connectome Analysis of FMRI Before and After Brain Tumor Resection. AMOS American Association of Physicists in Medicine (AAPM) Annual Meeting.
- Johnson J, Gule-Monroe M, Chen M, Ferguson SD, Chung C, Li J. Delayed FDG-PET in differentiating recurrent cerebral metastatic disease from radiation necrosis following stereotactic radiosurgery. 41st Annual Meeting of the European Society of Neuroradiology.
- Ott M, Zhou S, Wei J, De Groot J, Huse JT, McCutcheon I, Prabhu S, Ferguson S, Weinberg J, Sawaya R, Rao G, Lang F, Heimberger A. Glioma Immune Profiling Reveals Unique Immune Therapeutic Opportunities. Society of Neuro-Oncology (SNO) Annual Meeting.
- Metrus D, Harrison R, Ferguson, S, Weathers, SP. Isolated CNS Blastic Plasmacytoid Dendritic Cell Neoplasm in a Patient with AML. American Academy of Neurology 71st Annual Meeting.
- Hsu A, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen J, Liu H. Seed-based resting-state fMRI analysis for preoperative language mapping: A data-driven approach for guiding the seed selection. 7th Intraoperative Imaging Society Meeting.
- O'Brien JB, Sinicrope KD, Walker JF, Groves DM, Loghin EM, Seligman CE, Ferguson S, Weathers S, Matsuoka CK, Harrison R, Tummala S, Trevino RC, Peinado SJ, Murthy KR, Frederick J Groot D. Intrathecal Topotecan for Leptomeningeal Metastasis in Solid Tumors: The MD Anderson Experience. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Ferguson S. Preclinical modeling of leptomeningeal disease (LMD) from melanoma to facilitate therapeutic development. Society of Melanoma Research Annual Meeting.
- Chung, Caroline, Buszek, Marie S, Liu, Anthony H, Tran, Lucky B, Ferguson, S. Comparison of Radiomic Feature Variability between Different MR Pulse Sequences in Brain Metastases. AAPM|COMP Virtual Meeting.
- John I, Foster AP, Haymaker CL, Bassett RL, Lee J, Rohlfs ML, Richard J, Iqbal M, McCutcheon IE, Ferguson SD, Heimberger AB, Saberian CM, O'Brien BJ, Tummala S, Thakurta NG, Debnam M, Tawbi HA, Burton EM, Davies MA, Glitza IC. Intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD). American Society of Clinical Oncology (ASCO) Annual Meeting.
- Morad, G, Wong, MC, Fukumura, K, Huse, JT, Ferguson, SD, Ajami, NJ, Wargo, JA. Retrospective analyses of sequencing datasets suggest that intratumoral microbes exist in metastatic brain tumors. American Association of Cancer Research (AACR) Annual Meeting.
- Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian CM, Posada E, Gershenwald JE, Torres-Cabala CA, Huse JT, Tawbi HA, Glitza IC, Li J, Chung C, Yeboa D, Opusunju S, Kim BY, Lang FF, Haydu LE, Davies MA, Ferguson SD. Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Hasanov M, Milton DR, Patel SP, Tawbi HA, Glitza IC, Ferguson SD, Ledesma DA, Torres-Cabala CA, Lazar AJ, Burton EM, Gershenwald JE, Haydu LE, Davies MA. Incidence, timing, and predictors of CNS metastasis in patients (Pts) with clinically localized cutaneous melanoma (CM). American Society of Clinical Oncology (ASCO) Annual Meeting.
- Morad G, Damania A, Wong M, Johnson S, Sahasrabhojane P, Ajami N, Ferguson SD, Wargo J. The role of different microbiota in metastatic brain tumors. Leading Edge of Cancer Research Symposium: MD Anderson.
- Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A, Sonabend AM, Horbinski C, Verhaak R, Shankar A, Krishnan SN, Varn FS, Arrieta VA, Gupta P, Ferguson SD, Huse JT, Fuller GN, Long JP, Winkowski DE, Freiberg BA, James CD, Platanias LC, Lesniak MS, Burks JK, Heimberger AB. The central nervous system immune cell interactome is a function of cancer lineage, tumor microenvironment and STAT3 expression. American Association of Cancer Research (AACR) Annual Meeting.
- Morad G, Lastrapes M, Wong M, Sahasrabhojane P, Ferguson S, Ajami N, Wargo J. Distinct oral microbial signatures are associated with primary and metastatic brain tumors. American Association of Cancer Research (AACR) Annual Meeting.
- Amer A, Darbandi AD, Wang EB, Ciavarra BM, Lano KR, Krayyem A, Alhasan HR, Fuller GN, Ferguson SD, Loghin M, Li J, McGovern SL, Johnson JM. Clinical and pathologic characteristics of long-term glioblastoma survivors. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Tran B, Buszek S, Mitchell D, Long J, Elliott A, Langshaw H, Lily Erickson L, Farhat M, Bronk J, Ferguson S, Chung C. Combining Clinical Variables and Radiomic Features to Help Distinguish Radiation Necrosis from Tumor in Patients with Melanoma Brain Metastasis treated with Radiosurgery. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Tran B, Buszek S, Mitchell D, Long J, Elliott A, Langshaw H, Erickson L, Farhat M, Bronk J, Ferguson S, Chung C. Combining Clinical Variables and Radiomic Features to Help Distinguish Radiation Necrosis from Tumor in Patients with Melanoma Brain Metastases Treated with Radiosurgery. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian CM, Posada E, Gershenwald JE, Torres-Cabala DA, Huse JT, Tawbi HA, Glitza IC, Li J, Chung C, Yeboa D, Opusunju S, Kim BYS, Lang FF, Haydu LE, Davies MA, Ferguson SD. Changes in overall survival (OS) and prognostic factors in melanoma brain metastasis (MBM) patients (pts). Society of Melanoma Research Annual Meeting.
- Morad G, Damania AV, Wong MC, Sahasrabhojane P, Johnson SB, Ajami NJ, Ferguson SD, Wargo JA. Distinct microbial communities play a role in melanoma brain metastasis. Society of Melanoma Research Annual Meeting.
- Kumar S, Pelster MS, Hasanov M, Guerrieri RA, Hudgens CW, Ledesma D, Wang F, Fischer GM, Haydu LE, Katlowitz KV, Gopal YNV, McQuade JL, Kwong LN, Huse JT, Lazar AJ, Tetzlaff MT, Gershenwald JE, Joon AY, Chen K, Ram PT, Ferguson SD, Davies MA. Multivariate (MV) analysis of clinical, molecular and immune features associated with overall survival (OS) in patients (pts) with melanoma brain metastases (MBMs). Society of Melanoma Research Annual Meeting.
- Murthy RK, O'Brien B, Berry DA, Singareeka-Raghavendra A, Gule Monroe MG, Johnson J, White J, Childress J, Sanford J, Schwartz-Gomez J, Melisko M, Morikawa A, Ferguson S, de Groot JF, Krop I, Valero V, Rimawi M, Wolff A, Tripathy D, Lin NU, Stringer-Reasor E. Safety and efficacy of a tucatinib-trastuzumab-capecitabine regimen for treatment of leptomeningeal metastasis (LM) in HER2-positive breast cancer: Results from TBCRC049, a phase 2 non-randomized study. San Antonio Breast Cancer Symposium (SABCS).
- Murthy RK, O'Brien B, Berry DA, Singareeka-Raghavendra A, Monroe MG, Johnson J, White J, Childress J, Sanford J, Schwartz-Gomez J, Melisko M, Morikawa A, Ferguson S, Groot JF, Krop I, Valero V, Rimawi M, Wolff A, Tripathy D, Lin NU, Stringer-Reasor E. Safety and efficacy of a tucatinib-trastuzumab-capecitabine regimen for treatment of leptomeningeal metastasis (LM) in HER2-positive breast cancer: Results from TBCRC049, a phase 2 non-randomized study. San Antonio Breast Cancer Symposium.
- Bradshaw ME, Wefel JS, Noll KR, Rao G, Ferguson SD, Tawbi H, Huse J, Johnson J, Court L, O’Brien B, Lang F, Ejezie L, Sullaway C, Thomas A, Suki D, Yeboa DN. Baseline Patient-Reported Outcomes in an Ongoing Phase III Trial of Pre-Operative SRS vs. Post-Operative SRS for Brain Metastases. Society of Neuro-Oncology (SNO) Annual Meeting.
- Wefel J, Noll K, Rao G, Ferguson S, Tawbi H, Huse J, Johnson J, Court L, O'Brien B, Lang F, Ejezie L, Sullaway C, Thomas A, Suki D, Yeboa D. Neurocognitive Function and Neurocognitive Concerns in an Ongoing Phase III Trial of Pre-Operative SRS Vergus Post-Operative SRS for Brain Metastases. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Guerrieri F, Cortez J, Liu A, Jeong KY, Knighton B, Ferguson S, Davies M. Investigating the Role of Oxidative Phosphorylation (OXPHS) in CD4+ T cell Activation and Response to Anti-PD1/Anti-LAG3 Immunotherapy in Melanoma Brain Metastases (MBMs). SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Faraj CA, Ene C, Haider A, Suki D, Ferguson S, Heimberger A, McCutcheon I, Weinberg JS, Prahbu S, Lang F, Yeboa D, Li J, Briere T, Sawaya R. Response of Brain metastasis to Stereotactic Radiosurgery based on Tumor Size: The MD Anderson 23-year experience. American Association of Neurological Surgeons (AANS) Annual Meeting.
- Morad G, Tang Y, Duncan S, Ferguson S, Wargo JA, Burton EM, Davies MA, Liang H, Glitza Oliva IC. Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N). American Society of Clinical Oncology (ASCO) Annual Meeting.
- Teo JM, Kumar VA, Lee J, Eldaya RW, Hou P, Noll KR, Ferguson SD, Prabhu SS, Wintermark M, Anthony Liu HLA. Automated Detection of Resting-State Language Network in Brain Tumor Patients using Independent Component Analysis with MRI-derived Templates. American Association of Physicists (AAPM), Annual Meeting 2023.
- Erickson LG, Ramaswamy S, Ferguson SD, Long J, Hasanov M, Davies AB, Sirmans E, Saberian C, Posada EL, Malke J, Haydu LE, Tawbi H, Chung C. Identification of Time-Course Related, Treatment-Related, and Patient-Related Prognostic Factors in BRAF-MUTANT Melanoma Brain Metastases. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Guerrieri R, Cortez J, Liu A, Jeong K, Knighton B, Ferguson S, Davies M. Investigating the Role of Oxidative Phosphorylation (OXPHOS) in CD4+ T Cell Activation and Response to Anti-PD1/Anti-LAG3 Immunotherapy in Melanoma Brain Metastases (MBM). SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Erickson LG, Ramaswamy S, Ferguson SD, Hasanov M, Davies AB, Sirmans E, Saberian C, Posada EL, Malke J, Haydu LE, Tawbi H, Chung C. Identification of Time-Course Related Treatment-Related and Patient-Related Prognostic Factors in BRAF-Mutant Melanoma Brain Metastases. SNO/ASCO Annual Conference on CNS Clinical Trials & Brain Metastases.
- Glitza IC, Phillips S, John I, Bassett RL, Lin R, Rohlfs ML, Richard J, Iqbal M, Hennegan T, McCutcheon IE, Ferguson SD, O'Brien BJ, Tummala S, Guha- Thakurta N, Debnam M, Tawbi HA, Burton EM, Davies MA. Concurrent Intrathecal (IT) and Intravenous (IV) nivolumab (N) for melanoma (MM) patients (pts) with leptomeningeal disease (LMD)- Final Analysis. European Society of Medical Oncology (ESMO) 2023.
- Majd N, Yeboa D, Wang S, Weathers SS, Yuan Y, Ansarri HA, Kamiya-Matsuoka C, O-Brien BJ, Aaroe A, Patel CB, Dagher S, Wintermark M, Ferguson SD, Puduvalli VK, Liu SJ, Raleigh DR, Groot JF. Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Majd N, Yeboa D, Wang S, Weathers SS, Yuan Y, Anssari HA, Kamiya-Matsuoka C, O'Brien BJ, Aaroe A, Patel CB, Dagher S, Wintermark M, Ferguson SD, Puduvalli VK, Liu SJ, Raleigh DR, de Groot JF. Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Morad G, Damania AV, Melendez B, Wong MC, Sahasrabhojane PV, Johnson SB, Chelvanambi M, Dimitriou F, Losh JS, Ajami NJ, Ferguson SD, Wargo JA. Digital spatial profiling of metastatic brain tumors reveals association of the tumor microbiome with immune alterations in the tumor microenvironment. American Association of Cancer Research (AACR) Annual Meeting.
- Beckham TH, McAleer MF, Kudchadker R, Yeboa D, Tom MC, Perni S, Swanson T, Li J, Prabhu SS, Ferguson SD, McCutcheon IE, Yuan Y, Lang FF, Lin HY, Ene C, Weinberg AJ. A phase 3 randomized controlled trial of post-surgical stereotactic radiotherapy versus surgically targeted radiation therapy with GammaTile for treatment of newly diagnosed metastatic brain tumors. American Society of Clinical Oncology (ASCO) Annual Meeting.
- Davies MA, Simon J, Menzies AM, Milton DR, Wilmott JS, Ledesma DA, Burton EM, Ferguson SD, Tawbi HA, Gershenwald JE, Torres-Cabala CA, Glitza IC, Lazar AJ, Saw RP, Spillane AJ, Carlino MS, Scolyer RA, Long GV. Incidence and risk factors for central nervous system (CNS) metastasis (met) in patients (pts) with stage III melanoma treated with adjuvant (ADJ) anti-PD1 immunotherapy (IMT). American Society of Clinical Oncology (ASCO) Annual Meeting.
- O'Brien BJ, Murthy RK, Berry DA, Raghavendra AS, Gule-Monroe M, Johnson JM, Schwartz-Gomez J, Topletz-Erickson A, Lobbous M, Melisko ME, Morikawa A, Ferguson SD, de Groot JF, Krop IE, Valero V, Rimawi MF, Wolff AC, Tripathy D, Lin NU, Stringer-Reasor EM. Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in HER2+ breast cancer: TBCRC049 phase 2 study results. American Society of Clinical Oncology (ASCO) Annual Meeting.
Book Chapters
- Ferguson SD, Everson R, Wagner KM, Yeboa D, Sawaya R. Adult CNS Radiation Oncology. In: Neurosurgical Management of Single Brain Metastases. Springer, Cham, Chapter 31, 2018.
- Ferguson SD, McCutcheon IE. Meningitis and Encephalitis. In: Youmans & Winn Neurological Surgery. Seventh. Elsevier, 352, 2017.
- Ferguson SD, McCutcheon IE. Pituitary Tumors. In: UICC Manual of Clinical Oncology. Ninth. John Wiley & Sons, 609-625, 2015.
- Ferguson SD, LaRiviere MJ, Mansour N, Lesniak MS. Malignant Glioma: Chemovirotherapy. In: Tumors of the Central Nervous System. First. Springer, 357-364, 2011.
- Ferguson SD, Weathers SP, Heimberger AB. Immune Checkpoint Blockade in Glioma. In: Oligodendroglioma: Clinical, Presentation, Pathology, Molecular Biology, Imaging and Treatment.
- Ferguson SD, Tatsui CE, Rhines LD. Surgical Management of Spinal Sarcoma. In: Sarcoma Oncology: A Multidisciplinary Approach. First. People's Medical Publishing House.
Patient Reviews
CV information above last modified September 07, 2025